Skip to main content
Premium Trial:

Request an Annual Quote

Transition Technologies to Distribute SpectruMedix s Genotyping Platform in Canada

NEW YORK, Feb. 8 (GenomeWeb News) - Transition Technologies will distribute SpectruMedix's genotyping technology in Canada, the State College, Pa.-based company said today.

 

Under the agreement, Transition Technologies, based in Toronto, will market, sell, install, and service SpectruMedix's Reveal genetic-analysis platform in Canada.

 

Reveal is a non-specific detection method to identify genetic variations without prior knowledge of the size or sequence of the DNA amplicon, according to the company.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.